A new peer-reviewed paper has been published highlighting groundbreaking research that supports our lead asset therapy, MCO-010, and its potential to help restore vision in people living with retinal degenerative diseases. bit.ly/3IH0DgX#RP#fightblindness
We are proud to announce the initiation of a rolling submission of a BLA to the US FDA for our lead investigational therapy, MCO-010, for the treatment of severe vision loss due to #retinitispigmentosa#RPbit.ly/4nO7PYD#fightblindness
Excited that Dr. Mohapatra will present today at the Vitreo-Retinal Society-India Annual Conference. If you are there, do not miss his talk! #retinitispigmentosa#clinicaltrials#retina
Welcome Sunil Gupta, MD to the Nanoscope Therapeutics Inc. Board of Directors. Dr. Gupta is a nationally recognized retinal surgeon and a successful entrepreneur who brings deep experience in all phases of drug development and medical devices.
bit.ly/3YFkQrH